Literature DB >> 18695059

Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.

Sid E O'Bryant1, Stephen C Waring, C Munro Cullum, James Hall, Laura Lacritz, Paul J Massman, Philip J Lupo, Joan S Reisch, Rachelle Doody.   

Abstract

BACKGROUND: The Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) score is commonly used, although the utility regarding this score in staging dementia severity is not well established.
OBJECTIVE: To investigate the effectiveness of CDR-SOB scores in staging dementia severity compared with the global CDR score.
DESIGN: Retrospective study.
SETTING: Texas Alzheimer's Research Consortium minimum data set cohort. PARTICIPANTS: A total of 1577 participants (110 controls, 202 patients with mild cognitive impairment, and 1265 patients with probable Alzheimer disease) were available for analysis. MAIN OUTCOME MEASURES: Receiver operating characteristic curves were generated from a derivation sample to determine optimal cutoff scores and ranges, which were then applied to the validation sample.
RESULTS: Optimal ranges of CDR-SOB scores corresponding to the global CDR scores were 0.5 to 4.0 for a global score of 0.5, 4.5 to 9.0 for a global score of 1.0, 9.5 to 15.5 for a global score of 2.0, and 16.0 to 18.0 for a global score of 3.0. When applied to the validation sample, kappa scores ranged from 0.86 to 0.94 (P < .001 for all), with 93.0% of the participants falling within the new staging categories.
CONCLUSIONS: The CDR-SOB score compares well with the global CDR score for dementia staging. Owing to the increased range of values, the CDR-SOB score offers several advantages over the global score, including increased utility in tracking changes within and between stages of dementia severity. Interpretive guidelines for CDR-SOB scores are provided.

Entities:  

Mesh:

Year:  2008        PMID: 18695059      PMCID: PMC3409562          DOI: 10.1001/archneur.65.8.1091

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  14 in total

1.  Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R S Doody; J C Stevens; C Beck; R M Dubinsky; J A Kaye; L Gwyther; R C Mohs; L J Thal; P J Whitehouse; S T DeKosky; J L Cummings
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

2.  Reliability of the Washington University Clinical Dementia Rating.

Authors:  W J Burke; J P Miller; E H Rubin; J C Morris; L A Coben; J Duchek; I G Wittels; L Berg
Journal:  Arch Neurol       Date:  1988-01

3.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

4.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

Authors:  L Berg; D W McKeel; J P Miller; J Baty; J C Morris
Journal:  Arch Neurol       Date:  1993-04

7.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

Authors:  Michael Grundman; Ronald C Petersen; Steven H Ferris; Ronald G Thomas; Paul S Aisen; David A Bennett; Norman L Foster; Clifford R Jack; Douglas R Galasko; Rachelle Doody; Jeffrey Kaye; Mary Sano; Richard Mohs; Serge Gauthier; Hyun T Kim; Shelia Jin; Arlan N Schultz; Kimberly Schafer; Ruth Mulnard; Christopher H van Dyck; Jacobo Mintzer; Edward Y Zamrini; Deborah Cahn-Weiner; Leon J Thal
Journal:  Arch Neurol       Date:  2004-01

8.  Mapping scores onto stages: mini-mental state examination and clinical dementia rating.

Authors:  Robert Perneczky; Stefan Wagenpfeil; Katja Komossa; Timo Grimmer; Janine Diehl; Alexander Kurz
Journal:  Am J Geriatr Psychiatry       Date:  2006-02       Impact factor: 4.105

9.  Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

Authors:  J C Morris; M Storandt; D W McKeel; E H Rubin; J L Price; E A Grant; L Berg
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

10.  Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment.

Authors:  L Berg; J P Miller; M Storandt; J Duchek; J C Morris; E H Rubin; W J Burke; L A Coben
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

View more
  223 in total

1.  The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects.

Authors:  Mert R Sabuncu; Randy L Buckner; Jordan W Smoller; Phil Hyoun Lee; Bruce Fischl; Reisa A Sperling
Journal:  Cereb Cortex       Date:  2011-12-13       Impact factor: 5.357

2.  Antipsychotic Use in a Diverse Population With Dementia: A Retrospective Review of the National Alzheimer's Coordinating Center Database.

Authors:  Glen L Xiong; Teresa Filshtein; Laurel A Beckett; Ladson Hinton
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2015       Impact factor: 2.198

3.  Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.

Authors:  Ying Liu; Lan Tan; Hui-Fu Wang; Yong Liu; Xiao-Ke Hao; Chen-Chen Tan; Teng Jiang; Bing Liu; Dao-Qiang Zhang; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-08-23       Impact factor: 5.590

4.  Clinicopathological correlates of depression in early Alzheimer's disease in the NACC.

Authors:  Sarah T McCutcheon; Dingfen Han; Juan Troncoso; Vassilis E Koliatsos; Marilyn Albert; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-14       Impact factor: 3.485

5.  Incident Antipsychotic Use in a Diverse Population with Dementia.

Authors:  Teresa Filshtein; Laurel A Beckett; Haley Godwin; Ladson Hinton; Glen L Xiong
Journal:  J Am Geriatr Soc       Date:  2016-07-19       Impact factor: 5.562

6.  Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease.

Authors:  Lilah M Besser; Dawn P Gill; Sarah E Monsell; Willa Brenowitz; Dana H Meranus; Walter Kukull; Deborah R Gustafson
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

7.  The Dementia Severity Rating Scale predicts clinical dementia rating sum of boxes scores.

Authors:  Stephen T Moelter; Megan A Glenn; Sharon X Xie; Jesse Chittams; Christopher M Clark; Marianne Watson; Steven E Arnold
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Apr-Jun       Impact factor: 2.703

8.  Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.

Authors:  Mina Park; Yeonsil Moon; Seol-Heui Han; Ho Kyun Kim; Won-Jin Moon
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

9.  The link between C-reactive protein and Alzheimer's disease among Mexican Americans.

Authors:  Sid E O'Bryant; Leigh Johnson; Melissa Edwards; Holly Soares; Michael D Devous; Sarah Ross; Geoffrey Rohlfing; James Hall
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study.

Authors:  K L Triebel; R Martin; H R Griffith; J Marceaux; O C Okonkwo; L Harrell; D Clark; J Brockington; A Bartolucci; Daniel C Marson
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.